Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping
Authors:
- 12 December 2014
- journal article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 15 (1) , 1-3
Abstract
Clinical heterogeneity represents a great challenge for cancer therapeutics. Molecular classification of patients into different subtypes based on genetic or epigenetic characteristics has the potential to revolutionize the clinical care and mechanistic understanding of a wide spectrum of cancers, including endometrial carcinoma, the most common gynecological cancer affecting women.Keywords
This publication has 18 references indexed in Scilit:
- TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeuticsChinese Journal of Cancer, 2014
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Molecular pathology of endometrial carcinomaHistopathology, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian CancerJAMA, 2011
- The different roles of ER subtypes in cancer biology and therapyNature Reviews Cancer, 2011
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationProceedings of the National Academy of Sciences, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase MechanismCell, 2002